Eine Tageszeitung (Symbolbild).
Montag, 28.11.2016 22:50 von | Aufrufe: 71

DATATRAK Releases Powerful Clinical Trial Management System

Eine Tageszeitung (Symbolbild). pixabay.com

PR Newswire

CLEVELAND, Nov. 28, 2016 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), has released their innovative clinical trial management system, CTMS 360°. DATATRAK's CTMS is a robust, cloud-based, SaaS platform that will allow you to leverage your clinical study data with a top-of-class CTMS solution that seamlessly accesses data in real-time to provide the most current study status updates possible. Ad-hoc and custom reports empower DATATRAK ONE™ users to view immediate information faster and more efficiently than similar platforms.  

"Our first priority was to make sure that CTMS 360° was able to adapt to the needs of the user, not the user adapting to the platform," says Jim Bob Ward, CEO of DATATRAK. "We are able to do this by extending our highly versatile and proven technology, with new features that aren't seen in other CTMS platforms."  

CTMS 360° is not only highly configurable, but also delivers a first-of-its-kind Regulatory Submission tool, which tracks and templates submissions to regulatory bodies, simplifying and streamlining the process like never before.  

"One of the most complex parts of a clinical trial is the regulatory submission process," says Tim Lyons, VP, Product Development and Operations. "We are very excited to have developed a solution that will mitigate those pain-points while facilitating comprehensive management of your regulatory submissions with a solution that is completely unique to DATATRAK."

With CTMS 360°, DATATRAK ONE™ offers a cost-effective, pre-configured turn-key solution for same day use. For those not looking to assume the pre-configured options, CTMS 360°'s intuitive user friendly design empowers your Clinical Operations team to configure the system to your organization's workflows without the need for costly and complicated consultations and technical support. Should you choose, DATATRAK also offers onboarding support throughout the entire product configuration process.

"We want our clients to work with confidence knowing that our experts will be there to help them every step of the way with personalized support," says Lyons. "We have decades of industry experience, and it is our job to pass that knowledge on to our clients."   

DATATRAK International is a worldwide technology and services company delivering unified eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform, designed to accelerate the reporting of clinical research, with greater efficiency compared to other similar technologies. The DATATRAK ™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. For more information, please visit DATATRAK.com.


ARIVA.DE Börsen-Geflüster

Kurse

0,15 $
+100,0%
DATATRAK INTL INC Chart

LinkedIn  |  Twitter  |  Resources

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/datatrak-releases-powerful-clinical-trial-management-system-300369188.html

SOURCE DATATRAK International, Inc.

Werbung

Mehr Nachrichten zur DATATRAK INTL INC Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News